Rix, Peter J. External Author

Publications

Sort by

Selected publications

  • Phase I study of ARN-509, a novel antiandrogen, in the treatment of castration-resistant prostate cancer.  Journal of Clinical Oncology2013 Academic Article GET IT
    Times cited: 105
  • ARN-509: A novel antiandrogen for prostate cancer treatmentCancer Research2012 Academic Article GET IT
    Times cited: 245